Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
22 Dec 2025, 17:18:43 UTC
Prior SEC filing
26 Oct 2022
Next SEC filing
03 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Gladys Chang as Attorney-in-Fact

Key filing fact

Robert W. Fairbairn filed Form 4 for BlackRock Science & Technology Term Trust (BSTZ) on 22 Dec 2025.

Key facts

  • This page summarizes Robert W. Fairbairn's Form 4 filing for BlackRock Science & Technology Term Trust (BSTZ).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 22 Dec 2025, 17:18.

Change

  • Previous filing in this sequence was filed on 26 Oct 2022.
  • Current net transaction value: -$209,200.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001376962 Primary reporting owner

Fairbairn Robert W

Relationship
Director
Address
50 HUDSON YARDS, NEW YORK
Signature
/s/ Gladys Chang as Attorney-in-Fact
Signature date
22 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BSTZ transaction

Common Stock

Sale

Transaction value
$209,185
Shares
-9,293
Change %
-100%
Price
$22.51
Shares after
1
Date
18 Dec 2025
Ownership
Direct
BSTZ transaction

Common Stock

Sale

Transaction value
$14.7
Shares
-1
Change %
-100%
Price
$22.73
Shares after
0
Date
19 Dec 2025
Ownership
Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .